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Structure of an Autoimmune T Cell Receptor
Complexed with Class II Peptide-MHC:
Insights into MHC Bias and Antigen Specificity
the helical surface (70%–75%) is conserved and
evolved for biased recognition by the TCR, suggests
that TCR/pMHC interactions are tuned for the sampling
of different antigens (Daniel et al., 1998; Davis and Bjork-
man, 1988; Germain, 1990; Housset and Malissen, 2003;
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In support of this hypothesis, examples exist of struc-Stanford University School of Medicine
turally diverse, crossreactive peptides to a single T cellStanford, California 94305
clone (Bhardwaj et al., 1993; Crawford et al., 2004; Hag-2 Torrey Pines Institute for Molecular Studies
erty and Allen, 1995; Hemmer et al., 1998a; IgnatowiczSan Diego, California 92121
et al., 1997; Kersh and Allen, 1996b; Krogsgaard et al.,
2003; Loftus et al., 1999; Reiser et al., 2003; Sykulev et
al., 1994; Wucherpfennig and Strominger, 1995). While
some of these peptides retain recognizable sequenceSummary
similarities with the cognate peptides (Crawford et al.,
2004; Krogsgaard et al., 2003; Sykulev et al., 1998), otherT cell receptor crossreactivity with different peptide
crossreactive peptides have been shown to be minimallyligands and biased recognition of MHC are coupled
homologous in sequence and therefore presumably en-features of antigen recognition that are necessary for
gaging the TCR though a unique structural solutionthe T cell’s diverse functional repertoire. In the crystal
(Lang et al., 2002; Loftus et al., 1999; Reiser et al., 2003;structure between an autoreactive, EAE T cell clone
Wucherpfennig, 2004).172.10 and myelin basic protein (1–11) presented by
In contradiction to the notion of a promiscuous TCR,class II MHC I-Au, recognition of theMHC is dominated
most T cell clones are exquisitely sensitive to mutationsby the V domain of the TCR, which interacts with the
in the peptide (Shih and Allen, 2004). Some of the mostMHC  chain in a manner suggestive of a germline-
extensively studied TCR/MHC systems, such as 2B4/encoded TCR/MHC “anchor point.” Strikingly, there
I-Ek (Krogsgaard et al., 2003), 3L.2/I-Ek (Kersh et al.,are few specific contacts between the TCR CDR3
1998; Shih and Allen, 2004), KRN/I-Ag7 (Basu et al., 2000),loops and the MBP peptide. We also find that over
and 2C/H-2Kb (Degano et al., 2000; Sykulev et al., 1996),1,000,000 different peptides derived from combinato-
exhibit extremely specific peptide recognition and arerial libraries can activate 172.10, yet the TCR strongly
largely intolerant of amino acid changes in the TCR con-prefers the native MBP contact residues. We suggest
tacts. In most reported cases of degenerate TCR recog-that while TCR scanning of pMHC may be degenerate
nition, the TCR contact residues of the crossreactivedue to the TCR germline bias for MHC, recognition of
peptides are similar (Basu et al., 2000; Crawford et al.,structurally distinct agonist peptides is not indicative
2004; Grogan et al., 1999; Sykulev et al., 1998; Wilsonof TCR promiscuity, but rather highly specific alterna-
et al., 1999). Indeed, a single centrally located peptidetive solutions to TCR engagement.
residue is sufficient to produce tight selectivity by a TCR
(Degano et al., 2000; Ding et al., 1998; Krogsgaard et al.,Introduction
2003; Shih and Allen, 2004). Thus, the idea of degenerate
T cell recognition is difficult to reconcile with experimen-The engagement of the T cell receptor by peptide-MHC
tal observations of T cell specificity.
is the central antigen-specific event mediating the cellu-
To address these questions, we have been studying
lar immune response. The concept of an inherent TCR
TCR/pMHC interactions in murine experimental allergic
degeneracy has emerged to explain how a TCR is able encephalomyelitis (EAE), an intensively studied model
to recognize the diverse peptide antigens it encounters system, to understand autoimmunity to neural self-anti-
during the processes of thymic education and peripheral gens, such as myelin basic protein (MBP) (Zamvil and
surveillance (Ignatowicz et al., 1997; Nikolic-Zugic and Steinman, 1990). The immunodominant encephalito-
Bevan, 1990; Hemmer et al., 1998b; Holler and Kranz, genic T cell epitope of MBP, recognized by T cells in
2004; Kersh and Allen, 1996a; Mason, 1998; Wucher- mice of the H-2u haplotype (PL/J or B10.PL), is the acet-
pfennig, 2004). This concept has been buttressed by ylated N-terminal 11-mer (Ac1-11) (Zamvil et al., 1987).
biophysical studies of TCR/MHC interactions (Rudolph The Ac1-11 epitope in the context of class II MHC I-Au
and Wilson, 2002), which indicate that flexibility in the has a number of unusual features such as a very short
central CDR3 loops of the TCR may serve as an adapta- half-life (15 min.) and a requirement for an N-terminal
tion mechanism to “read out” different peptide antigens acetylation, and MBP peptides as short as Ac1-6 can
during TCR “scanning” of the universe of peptide-MHC still activate EAE T cell clones (Fairchild et al., 1993;
(Garcia et al., 1998; Willcox et al., 1999; Wu et al., 2002). Fugger et al., 1996; Gautam et al., 1994; Mason et al.,
The fact that peptide comprises a fraction (25%–30%) 1995; Wraith et al., 1992). A crystal structure of I-Au
of the composite pMHC surface, while the majority of complexed with MBP1-11 provided a rationale for these
properties by finding that the peptide sits in an unusual
shifted register in the groove, which results in empty p1*Correspondence: kcgarcia@stanford.edu
3 These authors contributed equally to this work. and p2 pockets, the MBP N terminus in the p3 pocket,
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and the peptide exiting the C-terminal end of the I-Au of the TCR V in both the number and specificity of
interactions with the MHC (Figure 2), and (2) an unusualgroove at the P7 position (He et al., 2002). The T cell
response to Ac1-11 has been extensively studied (Gov- chemistry of peptide recognition that exhibits poor
structural complementarity and few specific interactionserman, 1999) and exhibits highly biased TCR V8.2 chain
usage (Acha-Orbea et al., 1988; Urban et al., 1988; Fair- between either CDR3 or  and MBP1-11 peptide resi-
dues (Supplemental Table S2) (Figure 3). In the structure,child et al., 1993; Fugger et al., 1996; Gautam et al.,
1994; Mason et al., 1995; Wraith et al., 1992). the 172.10 footprint buries approximately 1160A˚2 of sur-
face area distributed roughly equally between V (54%)Here, we focus on the 172.10 T cell clone, which is
derived from encephalitogenic T cells isolated from and V (46%). On I-Au, a total of 1100A˚2 of surface area
is buried, with 867A˚2 attributable to the MHC helicesMBP-immunized H-2u mice (Goverman et al., 1993). We
previously measured the affinity of 172.10 for I-Au-Ac1- (79%) and only 233A˚2 to the peptide (21%). There are a
total of 44 amino acid contacts involving 127 atoms (van11 and found it to be within the ranges of normal cognate
TCR/pMHC interactions (KD5 M) (Garcia et al., 2001). der Waals plus hydrogen bonds) between the TCR and
I-Au-MBP1-11, with 35 interesidue contacts (92 atoms)Companion thermodynamic measurements suggested
flexibility in the TCR binding loops while binding to I-Au- between the TCR and the MHC helices (17 from V, 27
from V), and 9 inter-residue contacts between the TCRAc1-11, which may be favorable for degenerate recogni-
tion of structurally diverse peptides. In the present and MBP peptide (six van der Waals, 3 H bonds) involv-
ing 35 atoms. Overall, the 172.10/I-Au-MBP1-11 interac-study, we analyze the structure of the 172.10 TCR in
complex with I-Au-MBP1-11. In parallel, we used the tion has a shape complementarity (Sc) value of 0.62,
which is at the low end for protein-protein interactions172.10 T cell clone to scan a combinatorial decapeptide
library to identify an extensive panel of peptide mimo- and indicates a moderately poorly packed TCR/pMHC
interface.topes with a wide range of activities on the 172.10 clone.
The complementary results of these experiments have A striking observation is that the  chain contact with
the MHC helices is limited to 11 inter-residue van derimplications for our current understanding of TCR cross-
reactivity and biased recognition of MHC. Waals contacts (47 atoms) (Figure 2A), while the  chain
forms 24 helical contacts, 8 of which are hydrogen
bonds (totaling 80 atoms) (Figure 2B). Even though theResults
172.10 V (containing CDR1 and CDR2) buries a little
more than half of the total interface, it does not formOverall Structure
a single hydrogen bond with the MHC helices or anyThe 2.4 A˚ structure (see Experimental Procedures, and
contacts with the MBP peptide. The lack of peptideSupplemental Table S1 http://www.immunity.com/cgi/
contacts is clearly due to the register shift translatingcontent/full/22/1/81/DC1/) of the 172.10 single-chain
the MBP peptide out of range for CDR1 or 2 contactsVV heterodimer complexed to I-Au-MBP1-11 is remi-
(Figures 1 and 3). While there is excellent knob-in-holeniscent of previously determined class I and class II
TCR/pMHC complexes (Figure 1) (Hennecke et al., 2000; complementarity between V and the 1 helix resulting
Housset and Malissen, 2003; Reinherz et al., 1999; Ru- from van der Waals contacts (Figure 2A), the absence
dolph and Wilson, 2002). The TCR is oriented with the of any hydrogen bonds between the CDR1 and 2 and
V domain largely overlaying the N-terminal region of the MHC suggests a lack of tight specificity in these
the peptide and 1 helix and the V domain overlaying interactions. This characteristic is unexpectedly differ-
the C-terminal end of the peptide and the 1 helix (Fig- ent from the majority of TCR/pMHC complexes, in which
ures 1B and 1C). This docking orientation falls within the V domain dominates the pMHC interaction with
the 60 diagonal range seen in previous class I and respect to both buried surface and numbers of inter-
class II TCR/pMHC complexes (Hennecke and Wiley, atomic contacts (Rudolph and Wilson, 2002).
2001). An interesting deviation from previous TCR/ The 172.10 V domain shows much greater structural
pMHC complexes is due to the unusual binding register complementarity to the MHC surface than the V, form-
of the MBP peptide in the I-Au groove, where the peptide ing more than twice as many contacts (Supplemental
P1 residue (ala) occupies the p3 pocket, resulting in a Table S2) (Figure 2B). As 8 of these 24 amino acid con-
two-pocket shift of the entire peptide toward the tacts with the MHC are hydrogen bonds, this suggests
C-terminal end of the MHC groove (Figure 1B) (He et that the specificity of recognition of the I-Au helices is
al., 2002). As a result, the N terminus of the peptide sits largely dictated by the V, which is consistent with the
underneath the CDR3, which results in the majority of well-documented observation that the EAE T cell re-
the MBP peptide residing underneath the 172.10 V sponse is strongly biased toward V8.2 (Zamvil and
footprint (Figure 1C). In our recombinant protein, the Steinman, 1990). Residues unique to the V8.2 CDR1
MBP N-terminal acetylation is mimicked by a P-0-Gly and 2 form abundant specific contacts with residues on
residue (Radu et al., 1998), and three residual N-terminal the I-Au helices. For example, Asn31 of the V8.2 CDR1
peptide residues (colored in gray in Figure 1) remain makes a hydrogen bond with Gln61 on the I-Au 1 helix.
from the Drosophila leader peptide, making a number Additionally, CDR3 is “braced” on both sides of the
of van der Waals interactions with the TCR V (Supple- helical groove by main chain hydrogen bonds (Gly98
mental Table S2). N and Gly100O) to side chains on the 1 and 1 helices
(Gln61 and Arg70, respectively) (Figure 2B). These
interactions position the CDR3 Tyr-104 hydroxyl172.10 Interface with I-Au-MBP-1-11: Recognition
of the MHC Helices group for formation of a hydrogen bond with the P5-
Arg N1 atom of the MBP peptide. Thus, the explanationCollectively, the TCR/pMHC interface (Supplemental Ta-
ble S2) is striking in two respects: (1) the predominance for the V8.2 bias seems to be that the interactions
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Figure 1. Structure of TCR 172.10 in Complex with I-Au/MBP1-11
(A) Ribbon representation of the complex including 172.10V (red), 172.10V (blue), I-Au (green), and MBP residues 1–8 (yellow). The CDR
loops from 172.10 are colored as follows: CDR1 (magenta), CDR2 (pink), CDR3 (red), CDR1 (maroon), CDR2 (cyan), and CDR3 (blue).
(B) Side view (turned 90 from [A]) of the complex. MBP peptide is shown as a transparent molecular surface (yellow) with ball-and-stick
representations of amino acids inside, including the leader peptide (gray). The 1 helix from I-Au is in the front, and the 1 helix is behind
the peptide.
(C) 172.10 footprint showing docking orientation on I-Au/MBP1-11. Peptide-MHC is shown as a green surface (peptide in yellow, leader residues
in gray), and the 172.10 CDR loops are drawn as tubes and labeled. This and all subsequent figures were produced with PyMol (Delano, 2002).
between V8.2 and I-Au helices are optimal in the context quence at its apex, forms the only side-chain-specific
hydrogen bond from the TCR to the MBP peptide in theof specific MBP interactions with the CDR3.
complex structure (Figures 3B and 3C). The hydroxyl
group of CDR3 residue Tyr-104 forms a hydrogen172.10 Interface with I-Au-MBP-1-11: Recognition
of the MBP Peptide bond with the terminal N1 group of P5-Arg (Figures 3B
and 3C). Finally, P6-Pro sits in a pocket underneathThe CDR3 and  loops overlay the central region of
the I-Au groove, containing the amino-terminal region CDR3, forming van der Waals contacts with the side
chain of Asp-96 (Figure 3C). The structure of the long(P1 to P6) of the 11 residue MBP peptide (Figure 3).
There is no interaction from either germline-encoded V CDR3 appears compressed back into the TCR binding
site by the presence of the peptide. Given the thermody-or Vwith MBP, which is unique for TCR/pMHC complex
structures, which generally show some interaction be- namic data indicating unfavorable binding entropy of
172.10 for I-Au-MBP1-11 (Garcia et al., 2001), it appearstween the TCR CDR1 and  with peptide (Rudolph and
Wilson, 2002). likely that this loop has undergone conformational rear-
rangement upon binding. The peptide contacts with theThe interface chemistry of 172.10 is notable in that it
appears rather structurally degenerate in its recognition TCR rationalize the structure-function data of Ac1-11
recognition in the context of I-Au, which indicate that P3-of the MBP peptide, as evidenced by the paucity of
side-chain-specific hydrogen bonds (1) and salt bridges Gln, P5-Arg, and P6-Pro comprise the main recognition
epitope (Anderton et al., 1998; Gautam et al., 1994).(0) and the use of main-chain hydrogen bonds between
the CDR3 loops and peptide (Figure 3). CDR3 has a
main-chain hydrogen bond between the carbonyl oxy- Comparison of 172.10/I-Au-MBP1-11
with D10/I-Ak-CAgen of position Asn99 to the main-chain amide nitrogen
of P1-Ala of the MBP peptide. There is another main- The closest overall structural comparison that can be
made with the 172.10/I-Au-MBP1-11 complex (deter-chain hydrogen bond from the CDR3 Gly101 amide
nitrogen to the side chain of the MBP P3-Gln (Figures mined to 2.4 A˚) is with the D10/I-Ak-CA (conalbumin)
complex (determined to 3.2 A˚) (Reinherz et al., 1999)3A and 3C). CDR3, which contains a Gly-Gly-Gly se-
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Figure 2. 172.10 V and V Interactions with 1 and 1 Helices of I-Au
(A) Overview of the interface between 172.10 V (red) and V (blue) and I-Au (green)/MBP-peptide (yellow).
(B) Contact interface between the 172.10 V and the I-Au 1 helix. All contacts are van der Waals.
(C) Contact interface between the 172.10 V and the I-Au 1 helix showing both hydrogen bonds and van der Waals interactions. Labeled
residues are those involved in the hydrogen-bonding network.
(Figure 4). I-Au and I-Ak have eight and fifteen amino acid on the MHC helices (Bankovich and Garcia, 2003; Hous-
set and Malissen, 2003). However, in the case of thedifferences in the  and  chains, respectively, and D10
172.10/I-Au-MBP1-11 and D10/I-Ak-CA complexes, theand 172.10 both use V8.2. Therefore, CDR1 and CDR2
amino acids and the atomic structure of the contactof V are identical in the two TCRs. D10 uses V2 and
patch between CDR1, CDR2, and the 1 helix are172.10 uses the subgroup V2.3, which are highly similar
essentially identical with respect to both van der Waals(84% sequence identity) but contain amino acid differ-
interactions and hydrogen bonds (Figures 4B–4D). Theences in the CDR1 and 2 loops. An overlay of the
CDR1 and CDR2 residues Asn31, Tyr50, andfootprints of 172.10 and D10 reveals that the V domains
Glu56 share four hydrogen bonds and one salt bridgesuperimpose almost identically in an “orthogonal” orien-
with MHC  chain residues Gln-57, Gln61, and Lys-tation (discussed below) (Reinherz et al., 1999), but the
39 (Figures 4C and 4D), respectively. In addition, nu-172.10 V domain is rotated 15, shifting the 172.10
merous residues on the TCR and MHC form van derV footprint toward the end of the groove by approxi-
Waals interactions that are shared in both complexesmately 6 A˚ relative to D10 (Figure 4B). In 172.10, there
(Figures 4C and 4D). The preservation of these in-is no MBP contact by the V, whereas in D10 the majority
teratomic contacts is the result of conserved interactingof peptide contact is by the V, which is likely playing
residues on the I-Au and I-Ak 1 helices and CDR1 anda role in the divergence of the V footprints.
CDR2 (Figure 4D). This convergence of V docking
solutions has the important implication that there may
A TCR/MHC Anchor Point be a limited set of binding solutions for V8.2 onto I-A
Although all TCR/pMHC complex structures have MHC haplotypes (see Discussion).
roughly similar docking orientations, each complex
shows unique sets of TCR V domain contacts to MHC, Scanning the 172.10 T Cell Clone with Combinatorial
confounding the idea that there may exist “rules” for Peptide Libraries
TCR docking onto the MHC consisting of particular TCR Given the apparent dearth of specific contacts between
172.10 and MBP1-11, we asked whether this TCR maygermline residues interacting with conserved residues
Structure of an Autoimmune TCR/Peptide-MHC Complex
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Figure 3. 172.10 CDR3 Interactions with the
MBP Peptide
(A and B) Front view (A) with electron density
of the 172.10 CDR3 loop from the final 2.4 A˚
2Fo-Fc map and (B) side view of the 172.10
CDR3 loop. The 172.10V is in red, 172.10V
in blue, I-Au in green, and the MBP peptide
in yellow.
(C) The interface between the CDR3 loops
and the peptide binding groove, including rib-
bon representation of the 1 and 1 helix in
I-Au as well as the MBP peptide in ball and
stick. Hydrogen bonds between the loops
and the peptide are indicated as orange dots.
Not all residues shown are in contact (see
Supplemental Table S2).
be capable of recognition of other peptides in associa- in Figure 5, which shows the IL-2 response of the 172.10
hybridoma, to the 200 different library mixtures. Notetion with I-Au. We carried out a peptide library scan of the
172.10 T cell hybridoma using a synthetic combinatorial that the first library mixture with alanine fixed at position
1 (AX9) generates a signal substantially above back-peptide library containing all possible combinations of
N-acetylated decapeptides. Such library scans of a ground, reflecting a strong preference for P1-Ala. The
AX9 mixture used at a concentration of 100 g/ml con-given T cell clone lead to definition of a large number
of peptide analogs (100) of varying activity on the se- tains 320 109 different peptides, each at approximately
a concentration of 3  10	7 nM. A minimal estimate oflecting clone (Pinilla et al., 1999; Wilson et al., 1999). In
this study, a decamer peptide library is arrayed in a the degeneracy of the 172.10 clone can be calculated
by comparing the peptide concentration required to trig-positional scanning format and consists of 200 different
peptide mixtures, each one having one of the 20 amino ger a detectable response (EC10 3  10	10 M) with the
concentration of each peptide in the AX9 mixture (3 acids (O) in a defined position and all of the natural
L-amino acids except cysteine (A, D, E, F, G, H, I, K, L, 10	16 M). Such a comparison yields as many as 106 (3 
10	10/3  10	16) active peptides in the AX9 mixture thatM, N, P, Q, R, S, T, V, W, and Y) in stoichiometric amounts
in each of the remaining positions (OX9). For example, could have contributed to provide a detectable signal.
In addition to P1-Ala, P5-Arg is clearly dominant. Inthe first mixture has alanine (A) fixed in position 1 (AX9),
i.e, it contains all peptides with Ala at the N terminus, contrast, the two other TCR contact residues, P3-Gln
and P6-Pro, could possibly be substituted with semicon-while mixture 200 has tyrosine (Y) fixed in position 10
(X9Y), i.e, it contains peptides with Tyr at the C terminus. servative or nonconservative residues (Figure 6).
The scan information in Figure 5 provides aggregateEach OX9 mixture consists of 3.2  1011 (199) different
peptides. Given an average molecular weight of 1200 data that are an experimentally derived estimate of the
TCR degeneracy, but it does not yield individual peptideDa for a decapeptide mixture, when used at a concentra-
tion of 100 g/ml, the concentration of each individual sequences to test, as there are far too many active
candidates. Therefore, to reduce the number of candi-peptide in an OX9 mixture is 2.6  10	16 M.
The extent of degeneracy of the 172.10 clone is shown date mimotopes to a manageable size which could be
Immunity
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Figure 4. Structural Comparisons between 172.10/I-Au and D10/I-Ak Complexes
(A) The I-Ak molecule from the D10/I-Ak complex (PDBID 1D9K) was superimposed on I-Au in the 172.10/I-Au complex. The superposition is
represented as tubes; 172.10 is colored red, and D10 is colored blue, I-Au is colored green, and the MBP peptide is yellow. The region of
closest superposition (CDR1 and CDR2) is highlighted with a circle.
(B) Top view of the superposition with I-Au/MBP in surface representation including the CDR loops from 172.10 and D10 as tubes. The
differences in footprint for 172.10 and D10 on the I-A are shown as color-coded squares (red for 172.10, blue for D10).
(C) Shared hydrogen-bonding residues in the interface between the 1-helix (I-Au) and the CDR1 and 2 loops from 172.10 and D10. Hydrogen
bonds are indicated as orange dots and drawn for the 172.10/I-Au complex.
(D) Shared overall contacts between the V8.2 in both 172.10 and D10 with I-Au and I-Ak, respectively. Sequence alignments are between the
recognition surface of I-A  chains from residues 38 to 70, as well as between the CDR1 and 2 loops from 172.10 and D10. Residues
shaded in green are making contacts in both the 172.10/I-Au and D10/I-Ak complexes, while residues shaded red are only making contacts
in one of the complexes. Black lines are drawn between residues with conserved van der Waals contacts and orange dot lines for conserved
hydrogen bonds.
individually synthesized and tested, we screened a bi- that TCR contact residues P3-Gln and P6-Pro also can-
not be replaced by others in the set chosen based onased library (Figure 6A) with only those most prominent
amino acids that emerged from the library scans in Fig- the aformentioned criteria, but do not rule out alternative
allowed substitutions not tested in this experiment (An-ure 5. We included those amino acids corresponding to
the active mixtures causing a SI 
 mean  1 SD of all derton et al., 1998). In contrast, MHC binding residues
at P4 and P8 can utilize up to four residues, and P7 canof the mixtures for a given position and that ranked
among the four most active mixtures in three of four substitute lysine for alanine. The true extent of 172.10
degeneracy is larger than this experiment indicates be-different experiments.
The results of the biased library scan (Figure 6A) cause we tested a restricted subset of amino acids so
as to have a manageable library size that would ulti-clearly show a preferred set of residues that activate
the 172.10 clone containing P1-Ala, P3-Gln, P5-Arg, and mately yield individual sequences.
From this biased library, we individually synthesizedP6-Pro, which are the wild-type MBP TCR contacts in
the structure. As predicted from the library screen (Fig- and tested 128 peptides for activity (Figure 6B), of which
over half were more potent than MBP1-11. In all 128ure 5), the TCR contact residue P5-Arg is intolerant of
substitution. However, the biased library data indicate peptides, the P1-Ala, P3-Gln, P5-Arg, and P6-Pro are
Structure of an Autoimmune TCR/Peptide-MHC Complex
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Figure 5. Library Scan of the 172.10 Clone
Each panel represents each position of the
peptide in counterclockwise order. The pan-
els are labeled for position (P1, P2, etc.), and
the top hits at each position are labeled in
single-letter amino acid code. The x axis in
each panel indicates each of the 20 fixed
amino acids. The y axis indicates the IL-2
response of 172.10 cells to each library mix-
ture in terms of stimulation index (SI) deter-
mined in secondary cultures of HT2 cells with
supernatants from library-stimulated wells.
Solid horizontal lines indicate the mean SI
for all 20 mixtures within the panel; dashed
horizontal lines indicate mean SI plus 1 SD.
The gray bars indicate the amino acids of
the native Ac1-10 sequence. Stars indicate
amino acids selected at each position to gen-
erate candidate sequences. Amino acids se-
lected for synthesis of candidate mimic se-
quences, indicated at the top of Figure 6,
were those from fixed amino acid mixtures
with SIs greater than mean plus 1 SD. In some
instances, amino acids were also selected
on the basis that the corresponding mixtures
ranked among the four most active (of 20) in
three or four different experiments.
identical to that of MBP in the structure, which are the vealed that the TCR contacts are highly focused on the
native MBP amino acids. Although the peptide librariesprimary TCR contacts (Figure 3C; Supplemental Table
do not rule out the existence of alternative TCR contacts,S2). The peptides span a 6-log range in activity through
the clear trend is a preference for the native MBP resi-only varying residues other than TCR contacts, with
dues in the strong agonist ligands, contrary to the notionmost of the degeneracy in the C-terminal region of the
of a promiscuous TCR.peptide, which is likely outside of the groove (the molec-
We have also carried out a peptide library scan againstular basis of this is unclear).
another Ac1-11-specific T cell clone called 1934.4 (Gau-
tam et al., 1994), which has a similar focus on P5-Arg,
Discussion and P6-Pro, which are the presumed TCR contacts
(D.B.W., data not shown). A peptide scan was also car-
TCR degeneracy has been extensively discussed in or- ried out on the unrelated 2B4 TCR, which is specific for
der to rationalize the plurality of recognition require- I-Ek and moth cytochrome C and whose TCR and MHC
ments inherent in the life of the T cell (Kersh and Allen, contact residues have been precisely mapped by muta-
1996a; Mason, 1998; Wilson et al., 2004; Wucherpfennig, genesis (Krogsgaard et al., 2003). Similar to 172.10 and
2004). In the case of the 172.10 TCR, we see a TCR 1934.4, there was an almost complete intolerance to
interface with peptide that appears to lack robust pep- mutation of the TCR contacts and a strong modulatory
tide-specific interactions and is surrounded by a frame- effect of alterations in flanking amino acids (Krogsgaard
work of interactions between the TCR and MHC helices, et al., 2003).
many of which are conserved. This led us to question
whether other peptides could form more complemen- Defining Crossreactivity
tary interactions with 172.10 CDR3s than the MBP pep- The terms “crossreactive” TCR or “molecular mimic”
peptides have been used rather vaguely and often with-tide. However, the large peptide libraries we tested re-
Immunity
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Figure 6. Biased Library Scan and Activities of Individual Peptides
(A) The active fixed amino acid mixtures selected from Figure 5 are indicated at the top. We included those amino acids corresponding to
the active mixtures causing a SI 
 mean 1 SD of all of the mixtures for a given position and that ranked among the four most active mixtures
in three of four different experiments. The results of this scan are shown summarized at the bottom of the figure and indicated 128 different
possible different candidate peptides, each of which was synthesized and an EC50 was determined.
(B) Activity of selected candidate peptide analogs, out of 128, of Ac1-10 predicted by the biased library showing limited degeneracy tolerated
in the MBP sequence, and the effect of the C-terminal flanking residues on activity. For comparison, we also show the EC50 of wild-type
MBP Ac-1–10 (4Lys). The EC50 (nM) for each peptide is at the right.
out regard to whether the peptide sequence variations Wucherpfennig, 2004). In these cases, the TCR is un-
doubtedly recognizing unique structural epitopes. How-reflected direct TCR interactions or were simply alterna-
tive MHC anchors. Here, we can make a precise distinc- ever, these cases are probably not the result of a gener-
alized TCR promiscuity, but rather represent highlytion between alternative TCR contacts that would be
indicative of TCR crossreactivity versus peptides with specific, alternative structural solutions to engagement
of the TCR. For instance, for 172.10 the peptide scansonly variation in MHC binding residues. We suggest that
in many examples of TCR crossreactivity, it is probable did not identify individual peptides with different TCR
contacts, but the calculations of numbers of activatingthat the peptide-TCR contacts are similar to the cognate
peptide and are therefore not truly indicative of TCR peptides, based on the aggregate 172.10 stimulation
data, were far too many for us to individually test. Cer-degeneracy. As one example, in the KRN system a
crossreactive peptide was shown, using modeling and tainly, within the initial large library pool, structurally
unrelated peptides do exist that activate 172.10 yet arepeptide substitution assays, to precisely recapitulate,
rather than mimic in an alternative fashion, the TCR present in too low abundance or are too weak agonists
to emerge from the background.contacts of the cognate ligand (Basu et al., 2000). Simi-
larly, Lang et al. showed that a human myelin basic We suggest that TCR crossreactivity be defined based
on thresholds (Figure 7). In their normal functions, TCRsprotein peptide and an Epstein-Barr virus mimic pre-
sented structurally equivalent peptide-MHC surfaces scan an enormous array of pMHC complexes, largely
driven by biased TCR recognition of the MHC helicesthat would be recognized by the TCR, despite a lack of
sequence similarity (Lang et al., 2002). Therefore, the (Ignatowicz et al., 1997). It has been shown that T cells
require weak activation signals from self-pMHC in themimicry was achieved by preservation of specific TCR
contacts, without the need for TCR degeneracy. In the periphery; therefore, low-threshold crossreactivity is
probably required for the basal stimulation of the T cellmurine system, molecular mimic peptides have been
reported that are broadly active against MBP1-11-spe- (Stefanova et al., 2002). Hence, the baseline for TCR
crossreactivity is elevated in comparison to antibody/cific T cell clones; however, these mimic sequences all
contain the residues Arg-Pro, which are identical to two antigen interactions, which have no functional require-
ment for basal or low-threshold binding to diverse anti-of the MBP residues directly contacting 172.10 in our
complex (Gautam et al., 1998; Grogan et al., 1999). gens (Figure 7). The antibody molecule has high-thresh-
old (i.e., affinity) and narrow specificity recognitionThere are clear functionally relevant examples of TCRs
which recognize unrelated peptide sequences that are properties, as shown by a general intolerance to ligand
structural alterations exemplified by viral escape mu-potent agonists compared to the cognate antigen (Lof-
tus et al., 1997; Reiser et al., 2003; Sykulev et al., 1994; tants (Mateu, 1995). We propose that TCRs share a simi-
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found that the five shared MHC contact residues be-
tween I-Ak and I-Au are also conserved (Figure 4D). This
is further suggestive that the V8.2/I-A contact residues
in the structures may be a generalized I-A recognition
motif.
The fact that the V2 complexes with class I MHC
H-2Kb have not revealed a similar conservation of con-
tacts may be due to class I TCR/pMHC complexes
allowing more variation in TCR orientation relative to
class II (Reinherz et al., 1999). There is a broader “peak”
on the surface of class II MHC that more narrowly con-
strains the rotational freedom of the TCR bound to class
II MHC (Reinherz et al., 1999). Second, the V in 172.10
(V2.3) and D10 (V2) are closely related, perhaps facili-
tating the V convergence we are seeing. Similar to
the “sets” of peptide anchor residues used by MHC
(Rammensee et al., 1995), it is likely that sets of TCR
interaction motifs will exist for each TCR chain type
(both  and  chain) with each MHC haplotype.
Autoimmunity
Mice transgenic for the 172.10 TCR spontaneously de-Figure 7. Specificity versus Degeneracy in Antigen Recognition
velop EAE at a relatively high frequency (Goverman,For each panel, the y axis represents an arbitrary measure of affinity
1999). An important question is how the binding chemis-or activity, and the x axis denotes a unitless measure of ligand
structural diversity. An antibody generally exhibits high specificity try of this autoreactive TCR compares to normal cognate
and affinity with narrow tolerances for mutation (top panel). TCRs TCR/self-pMHC interactions. The most conspicuous
are sometimes considered broadly degenerate (middle panel). We structural feature of the 172.10/I-Au-MBP1-11 complexsuggest that TCRs are highly specific for activating peptide ligands,
is the recognition of the frame-shifted MBP peptide.with a narrow tolerance for mutation, but also possess a low-thresh-
Wild-type MBP (P4-Lys) has a very short half-life (15old background level of crossreactivity consistent with pMHC scan-
ning (bottom panel). min) bound to I-Au, which may predispose it to a short
lifetime in the thymus, leading to ineffective deletion of
autoreactive TCRs (Fairchild et al., 1993). In vivo, the
lar narrow specificity for structurally unrelated peptides focus of 172.10 on contacts with the transiently bound
at the higher thresholds that lead to full T cell activation, wild-type MBP peptide would prevent formation of TCR/
rather than being part of a simple continuum of cross-
pMHC complexes of sufficient half-life for signaling, re-
reactive TCR ligands.
sulting in inefficient negative selection. Consistent with
this interpretation, the stable P4-Tyr MBP variant hasTCR Bias for MHC
been shown to block development of EAE, presumablyOne of the puzzling generalizations that has emerged
through deletion of MBP-reactive T cells (Anderton etfrom the TCR/pMHC complex structures so far is a
al., 2001). In the periphery, 172.10 T cells will ultimatelyroughly convergent docking orientation (45 diagonal),
lead to development of EAE in mice transgenic for thisin spite of a lack of common sets of interatomic contacts
TCR (Goverman, 1999). Perhaps over time and manybetween TCR and MHC (Housset and Malissen, 2003).
collective encounters, the TCR germline-encoded inter-For example, in structures of different V2-containing
actions with the surrounding MHC helices provide theTCRs in complex with H-2Kb, the CDR1 and CDR2
stabilizing influence necessary to overcome the tran-have different binding registers when docked to the
sient peptide occupancy for priming of MBP-specificH-2Kb 1 helix (Housset and Malissen, 2003). The ques-
TCR, leading to full activation and autoimmunity. Antion has arisen, then, of whether the TCR V-gene reper-
additional factor to consider in this complex is that, duetoire encodes the biased docking orientation of MHC in
to the peptide frame shifting, the N-terminal third of thethe amino acids on the CDR1 and 2 loops, or whether
peptide groove is empty when Ac1-11 is bound, whichexternal factors such as coreceptors (CD8, CD4) may
is the region of the groove overlaid by the V domain.influence the orientation of the TCR through steric ef-
The empty pockets in the groove may prevent obstruc-fects during thymic selection (Buslepp et al., 2003).
tionist peptide contacts that would normally interfereIn our structure, we see that V8.2 of the 172.10 and
with binding of MBP-specific TCR carrying certain D10 TCRs superimpose essentially identically at a large
chains. Finally, our initial supposition that a highly de-multipoint contact patch between CDR1 and CDR2
generate peptide repertoire might further facilitate theand the MHC 1 helix (Figure 4). This shared contact
autoimmunity of 172.10 has not been supported by ourpatch is composed of five shared TCR residues inter-
peptide library results. On the contrary, it may be that theacting with five shared MHC residues and comprises
highly specific recognition of I-Au-Ac1-11 might serve73% of the total V interaction surface with the I-Au
to focus T cell activation on the MBP peptide without1 helix. (Figures 4C and 4D). We also aligned the se-
quences of I-A haplotypes d, b, s, q, g7, r, and f and competition from crossreactive ligands.
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Experimental Procedures where O represents one each of the 20 natural L-amino acids in a
defined position, and X represents all of the natural amino acids,
with the exception of cystein (C), in each of the remaining positions.Expression
The 172.10 TCR was expressed as a single-chain Fv (scTCR). The For example, the first mixture has alanine (A) in position 1 (A1X9),
whereas mixture number 200 has tyrosine (Y) in position 10 (X9Y10).variable domains of the 172.10 T cell receptor were amplified by
PCR and joined with a cassette encoding a 20 amino (Gly4Ser)4 Each OX9 mixture consists of 3.2  1011 (199) different decamer
peptides in approximate equimolar concentration, and the total X10linker, which proved to be the optimal linker length after testing a
number of versions. Four amino acid substitutions were introduced library consists of 6.4 1012 (20 1019) different peptides. Assuming
an average molecular weight of 1200 Da for a decapeptide mixtureinto the V framework that had been shown to increase expression
levels and solubility in V8.2 TCR (G17E, H47Y, I75T, and L78S) in and a concentration of 100 g/ml (83 M), the concentration of each
individual peptide is 2.6  10	16 M.a series of pilot studies (Garcia et al., 2001; Shusta et al., 1999; J.M.
et al., unpublished data). Linker and amino acid substitutions were Small (milligram quantities) of individual candidate peptides were
synthesized by solid-phase synthesis using standard Fmoc chemis-introduced via oligonucleotide-directed mutagenesis and overlap
PCR prior to ligating the modified gene into the bacterial expression try and a Spyder multiple-peptide synthesizer. The Spyder synthe-
sizer is formatted to synthesize up to 192 individual peptide se-vector pAK400 (Krebber et al., 1997) via directional SfiI-SfiI restric-
tion sites and sequencing. Protein was expressed in the periplasm quences in two 96-well plates. This formatting is designed so that
the synthesized peptides can be cleaved from their solid supportof E. coli strain BL21, extracted by a modified osmotic shock proce-
dure, and purified to95% by sequential immobilized metal affinity, while still in the plates and then extracted robotically into two new
sets. The first set was placed in an automated LC-MS system forS75 size exclusion, and anion exchange chromatographic steps.
The C-terminal histidine tag was removed by overnight digestion at analysis, and the second set was lyophilized and used for biologi-
cal screening.4C with a 1:100 mass ratio of carboxypeptidase A (Calbiochem)
prior to the size-exclusion step. As a final step, the proteins were Larger, bulk synthesis quantities of individual peptides was ac-
complished by the simultaneous multiple-peptide synthesis methodconcentrated by Centricon-10 (Millipore) to35 mg/ml in HBS, ster-
ile filtered, and stored at 4C. I-Au was expressed and purified from a (Houghten, 1985) or with an automated peptide synthesizer (ABI,
Foster City, CA). Purity and identity of each peptide was character-stably transfected Drosophila cell line as described (He et al., 2002).
ized using an electrospray mass spectrometer interfaced with a
liquid chromatography system.Crystallization
Crystals of 172.10 scTCR and I-Au MHC (1:1 molar ratio; 35 mg/ml
total protein concentration) were grown from 21% PEG-3350, 0.1 Culture Conditions
M HEPES (pH 7.5), and 0.2 M lithium sulfate in the sitting drop format The 172.10 T cell hybridoma cells, reactive to MBP Ac1-9 (Goverman
to0.2 0.4m size and were cryo-cooled for X-ray data collection et al., 1993), were cultured in triplicate in round-bottom microwells
in the presence of 25% glycerol. A complete data set was collected (50  103 cells/well) with irradiated (3000 R) ammonium chloride
from one crystal at beamline 8.2.1 at the Berkeley Advanced Light Tris-buffer-treated B10.PL splenic cells as APCs (250  103 cells
Source (ALS, Berkeley, CA) using 1.08 A˚ wavelength X-rays and an per well) and peptide library mixtures (100 g/ml) or with varying
ADSC Quantum 210 CCD detector. A total of 120 of 1 oscillation concentrations of individual peptides for 24 hr. IL-2 responses were
images were collected under cryogenic conditions (T  100 K). The assessed in recovered supernatants (50 l) added to secondary, 24
data were indexed, integrated, and scaled with HKL2000 in space hr cultures of IL-2-addicted HT2 cells (2000 per well). The extent of
group C2221, with unit cell dimensions a  87.84 A˚, b  327.16 A˚, IL-2-dependent HT2 cell proliferation was determined with 3H-Tdr
c  127.16 A˚,       90, and two complexes per asymmetric added during the last 4 hr.
unit (mosaicity  0.5). The crystal diffracted to 2.4 A˚ resolution,
and the final data set had an overall Rsym of 6.1% and completeness Determination of EC50 Values
of 96%. Details of the data and refinement statistics are given in T cell populations were cultured using conditions described pre-
Supplemental Table S1. viously with varying dilutions of peptides (Judkowski et al., 2001;
Wilson et al., 1999). The concentration of peptide causing a half-
Structure Determination and Refinement maximal IL-2 response (EC50) was determined by curve fitting, using
The structure was determined by molecular replacement using the a scientific graphics software program (GraphPad Prism; Graph Pad
MOLREP program as implemented in the CCP4 package (CCP4, Software, San Diego, CA). The maximal IL-2 response was fixed
1994). The D10 TCR from theI-Ak/D10-CA (PDB ID: 1d9k) complex using the mean of the highest values obtained in each experiment.
was used as the TCR model, and our previous I-Au-MBP1-11 struc-
ture was used as the starting model for the MHC (He et al., 2002). Acknowledgments
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